Cargando…
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
BACKGROUND: Identifying a meaningful progression metric for Parkinson’s disease (PD) that reflects heterogeneity remains a challenge. OBJECTIVE: To assess the frequency and baseline predictors of progression to clinically relevant motor and non-motor PD milestones. METHODS: Using data from the Parki...
Autores principales: | Brumm, Michael C., Siderowf, Andrew, Simuni, Tanya, Burghardt, Elliot, Choi, Seung Ho, Caspell-Garcia, Chelsea, Chahine, Lana M., Mollenhauer, Brit, Foroud, Tatiana, Galasko, Douglas, Merchant, Kalpana, Arnedo, Vanessa, Hutten, Samantha J., O’Grady, Alyssa N., Poston, Kathleen L., Tanner, Caroline M., Weintraub, Daniel, Kieburtz, Karl, Marek, Kenneth, Coffey, Christopher S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578214/ https://www.ncbi.nlm.nih.gov/pubmed/37458046 http://dx.doi.org/10.3233/JPD-223433 |
Ejemplares similares
-
Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
por: Chahine, Lana M., et al.
Publicado: (2019) -
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
por: Simuni, Tanya, et al.
Publicado: (2018) -
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
por: Marek, Kenneth, et al.
Publicado: (2018) -
Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
por: Weintraub, Daniel, et al.
Publicado: (2023) -
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)